HEPA

Hepion Pharmaceuticals

Delisted

HEPA was delisted on the 12th of May, 2025.

3 hedge funds and large institutions have $8.61M invested in Hepion Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$907K

Top Sellers

1 -$4.41M
2 -$3.4M
3 -$1.82M
4
Morgan Stanley
Morgan Stanley
New York
-$333K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$240K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.63M
2
$1.85M
3
$626K
4
$493K
5
$354K
6
$287K
7
$267K
8
$214K
9
$202K
10
$142K
11
$93K
12
$65K
13
$46K
14
$46K
15
$38K
16
$37K
17
$30K
18
$30K
19
$29K
20
$27K
21
$23K
22
$19K
23
$18K
24
$14K
25
$11K